The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
127832461 12783246 1 I 20160915 20160927 20160927 EXP GB-MLMSERVICE-20160912-0407541-1 GB-ALKEM LABORATORIES LIMITED-GB-ALKEM-2016-00194 ALKEM 61.00 YR M Y 0.00000 20160927 CN GB GB

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
127832461 12783246 1 PS MYCOPHENOLATE MOFETIL. MYCOPHENOLATE MOFETIL 1 UNKNOWN Y 91249
127832461 12783246 2 SS MYCOPHENOLATE MOFETIL. MYCOPHENOLATE MOFETIL 1 2.5 G, QD Y 91249 2.5 G QD
127832461 12783246 3 SS INFLIXIMAB INFLIXIMAB 1 5 MG/KG, INTRODUCED AT WEEKS 0, 2, AND 6, AND 8-WEEKLY THEREAFTER Y 0 5 MG/KG INFUSION
127832461 12783246 4 SS INFLIXIMAB INFLIXIMAB 1 5 MG/KG,6 WEEKS Y 0 5 MG/KG INFUSION
127832461 12783246 5 SS PREDNISOLONE. PREDNISOLONE 1 1.5 MG/KG, UNK Y 0 1.5 MG/KG
127832461 12783246 6 SS PREDNISOLONE. PREDNISOLONE 1 40-60 MG, QD Y 0 QD
127832461 12783246 7 SS PREDNISOLONE. PREDNISOLONE 1 20 MG, QD Y 0 20 MG QD
127832461 12783246 8 SS PREDNISOLONE. PREDNISOLONE 1 40 MG, QD Y 0 40 MG QD
127832461 12783246 9 C METHYLPREDNISOLONE. METHYLPREDNISOLONE 1 Intravenous (not otherwise specified) 1 G, 3 ? 1 G 0 1 G
127832461 12783246 10 C METHYLPREDNISOLONE. METHYLPREDNISOLONE 1 UNKNOWN 0
127832461 12783246 11 C AZATHIOPRINE. AZATHIOPRINE 1 UNKNOWN Y Y 0
127832461 12783246 12 C SULFAMETHOXAZOLE AND TRIMETHOPRIM SULFAMETHOXAZOLETRIMETHOPRIM 1 480 MG, THRICE A WEEK 0 480 MG
127832461 12783246 13 C TRIAMCINOLONE TRIAMCINOLONE 1 Ophthalmic UNKNOWN 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
127832461 12783246 1 Immunosuppression
127832461 12783246 3 Uveitis
127832461 12783246 5 Uveitis
127832461 12783246 9 Uveitis
127832461 12783246 11 Uveitis
127832461 12783246 12 Lymphopenia
127832461 12783246 13 Product used for unknown indication

Outcome of event

Event ID CASEID OUTC COD
127832461 12783246 OT
127832461 12783246 HO
127832461 12783246 LT

Reactions reported

Event ID CASEID DRUG REC ACT PT
127832461 12783246 Intestinal ischaemia
127832461 12783246 Intestinal obstruction
127832461 12783246 Multiple organ dysfunction syndrome
127832461 12783246 Pneumocystis jirovecii infection
127832461 12783246 Pneumonia
127832461 12783246 Sepsis

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found